5:32 PM
Dec 19, 2012
 |  BC Extra  |  Company News

Sage, H3 in deal covering cancer pharmacogenomic profiling

H3 Biomedicine Inc. (Cambridge, Mass.) partnered with not-for-profit Sage Bionetworks (Seattle, Wash.) to develop a "pipeline" of pharmacogenomic profiling data...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >